Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5189890
Max Phase: Preclinical
Molecular Formula: C24H45N5O14
Molecular Weight: 627.65
Associated Items:
ID: ALA5189890
Max Phase: Preclinical
Molecular Formula: C24H45N5O14
Molecular Weight: 627.65
Associated Items:
Canonical SMILES: NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H]4[C@@H](OC[C@@H]4O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O
Standard InChI: InChI=1S/C24H45N5O14/c25-2-8-13(33)14(34)10(28)22(38-8)42-19-9(3-30)39-24(16(19)36)43-21-12(32)5(26)1-6(27)17(21)40-23-11(29)15(35)20-18(41-23)7(31)4-37-20/h5-24,30-36H,1-4,25-29H2/t5-,6+,7+,8+,9-,10-,11-,12+,13-,14-,15-,16-,17-,18-,19-,20+,21-,22-,23+,24+/m1/s1
Standard InChI Key: JBUIZTYWJOTGFA-GKBYVZNRSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 627.65 | Molecular Weight (Monoisotopic): 627.2963 | AlogP: -8.46 | #Rotatable Bonds: 8 |
Polar Surface Area: 336.32 | Molecular Species: BASE | HBA: 19 | HBD: 12 |
#RO5 Violations: 3 | HBA (Lipinski): 19 | HBD (Lipinski): 17 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 12.17 | CX Basic pKa: 9.59 | CX LogP: -7.78 | CX LogD: -13.69 |
Aromatic Rings: 0 | Heavy Atoms: 43 | QED Weighted: 0.12 | Np Likeness Score: 1.38 |
1. Pirrone MG, Hobbie SN, Vasella A, Böttger EC, Crich D.. (2021) Influence of ring size in conformationally restricted ring I analogs of paromomycin on antiribosomal and antibacterial activity., 12 (9.0): [PMID:34671740] [10.1039/D1MD00214G] |
Source(1):